- The new plant produces aluminum-based coagulants for water treatment.
- It is located on Bayer MaterialScience's site in Dormagen, Germany.
- The plant uses hydrochloric acid, a by-product from Bayer's TDI production.
- This facility has the largest polyaluminumchloride (PAX) production capacity globally.
Production Capabilities
Kemira's new coagulant plant in Dormagen, Germany, has successfully started operations. The facility is capable of producing the full range of Kemira's aluminum-based coagulants, which are essential for drinking water and wastewater treatment.
Strategic Location
The plant is situated on Bayer MaterialScience's site, ensuring a sustainable and long-term supply of raw materials. This strategic location allows Kemira to utilize hydrochloric acid, a by-product from Bayer's production of toluene diisocyanate (TDI), in its coagulant manufacturing process.
Market Impact
With the largest polyaluminumchloride (PAX) production capacity in the world, the Dormagen plant is crucial for maintaining Kemira's leadership in the municipal and industrial water treatment market in the EMEA region. The integration with Bayer MaterialScience provides significant economic and environmental advantages.
Manufacturing Footprint
The establishment of the Dormagen plant is a key step in consolidating Kemira's manufacturing footprint for coagulants in the EMEA region, enhancing the company's operational efficiency and market presence.
